Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AF Nucleoside and nucleotide reverse transcriptase inhibitors
J05AF07 Tenofovir disoproxil
D01982 Tenofovir disoproxil fumarate (JAN/USAN) <JP/US>
USP drug classification [BR:br08302]
Antivirals
Anti-hepatitis B (HBV) Agents
Tenofovir
D01982 Tenofovir disoproxil fumarate (JAN/USAN)
Anti-HIV Agents, Nucleoside and Nucleotide Reverse Transcriptase Inhibitors (NRTI)
Tenofovir
D01982 Tenofovir disoproxil fumarate (JAN/USAN)
Therapeutic category of drugs in Japan [BR:br08301]
6 Agents against pathologic organisms and parasites
62 Chemotherapeutics
625 Antivirals
6250 Antivirals
D01982 Tenofovir disoproxil fumarate (JAN/USAN)
Drug groups [BR:br08330]
Antiviral
DG01890 Nucleoside reverse transcriptase inhibitor (NRTI)
DG01223 Tenofovir
D01982 Tenofovir disoproxil fumarate
DG03107 Anti-HIV agent
DG01656 HIV reverse transcriptase inhibitor
DG01223 Tenofovir
D01982 Tenofovir disoproxil fumarate
Drug classes [BR:br08332]
Antiviral
DG03107 Anti-HIV agent
D01982 Tenofovir disoproxil fumarate
Antimicrobials [BR:br08307]
Antivirals
Genome replication inhibitor
HBV reverse transcriptase inhibitor
D01982 Tenofovir disoproxil fumarate (JAN/USAN) <JP/US>
Antimicrobials abbreviations [BR:br08327]
Antivirals
Genome replication inhibitor
HBV reverse transcriptase inhibitor
D01982 Tenofovir disoproxil fumarate (JAN/USAN)
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D01982
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D01982
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D01982
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D01982
Prodrugs [br08324.html]
D01982
Drug groups [BR:br08330]
Antiviral
DG01890 Nucleoside reverse transcriptase inhibitor (NRTI)
DG01223 Tenofovir
DG03107 Anti-HIV agent
DG01656 HIV reverse transcriptase inhibitor
DG01223 Tenofovir
Other DBs
CAS:
202138-50-9
PubChem:
7849044
ChEBI:
63718
LigandBox:
D01982
NIKKAJI:
J1.996.151F
KCF data
ATOM 43
1 C6a C 30.8992 -18.5945
2 C2b C 32.1576 -19.2936
3 C2b C 33.3460 -18.5945
4 C6a C 34.5345 -19.2936
5 O6a O 35.7928 -18.5945
6 O6a O 29.7108 -19.2936
7 O6a O 30.8992 -17.1963
8 O6a O 34.5345 -20.6917
9 C8y C 26.5368 -16.8840
10 C8y C 26.5368 -15.4243
11 N4y N 25.2162 -17.3012
12 N5x N 27.7880 -17.5096
13 N5x N 25.2162 -15.0073
14 C8y C 27.7880 -14.7987
15 C8x C 24.3820 -16.1889
16 C8x C 28.9697 -16.8840
17 N5x N 28.9697 -15.4243
18 N1a N 27.7880 -13.4085
19 C1b C 25.2162 -18.6945
20 C1c C 24.0155 -19.3876
21 O2a O 22.8023 -18.6870
22 C1b C 21.5805 -19.3928
23 P1b P 20.3622 -18.6904
24 O2b O 19.1554 -17.9937
25 O2b O 19.6691 -19.8908
26 O3b O 21.0616 -17.4784
27 C1b C 19.1554 -16.5955
28 C1b C 19.6691 -21.2890
29 O7a O 17.9438 -15.8681
30 C7a C 16.7329 -16.5671
31 O7a O 15.5220 -15.8681
32 C1c C 14.3112 -16.5671
33 C1a C 13.1003 -15.8681
34 O7a O 18.4331 -22.0200
35 C7a C 17.2222 -21.3209
36 O7a O 16.0114 -22.0200
37 C1c C 14.8006 -21.3209
38 C1a C 13.5897 -22.0200
39 O6a O 16.7329 -17.9651
40 C1a C 14.3112 -17.9652
41 O6a O 17.2222 -19.9230
42 C1a C 14.8006 -19.9229
43 C1a C 24.0154 -20.7900
BOND 43
1 1 2 1
2 2 3 2
3 3 4 1
4 4 5 1
5 1 6 1
6 1 7 2
7 4 8 2
8 10 13 1
9 10 14 1
10 11 15 1
11 12 16 2
12 14 17 2
13 13 15 2
14 16 17 1
15 9 10 2
16 9 11 1
17 9 12 1
18 14 18 1
19 11 19 1
20 19 20 1
21 20 21 1
22 21 22 1
23 22 23 1
24 23 24 1
25 23 25 1
26 23 26 2
27 24 27 1
28 25 28 1
29 27 29 1
30 29 30 1
31 30 31 1
32 31 32 1
33 32 33 1
34 28 34 1
35 34 35 1
36 35 36 1
37 36 37 1
38 37 38 1
39 30 39 2
40 32 40 1
41 35 41 2
42 37 42 1
43 20 43 1 #Up